Mr. Broussard was listed No. 19 on the list. Fortune curated its rankings based on how leaders performed on 10 metrics, ranging from return on capital to total investor return.
Mr. Broussard has been CEO of Humana since 2011. Before joining Humana, he was CEO of McKesson Specialty/US Oncology.
More articles on payers:
Radiologists to Cigna: Revise hospital-based imaging policy to avoid harming pediatric patients
UnitedHealth expects $277B+ in revenue in 2021
13 insurers extending COVID-19 cost-sharing waivers into 2021
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
